Management in travelers returning from tropical countries with fever

2023-06-05
Nandini Chatterjee

Nandini Chatterjee, MD, is a professor of medicine in the Institute of Post Graduate Medical Education and Research (IPGMER) in Kolkata, India, and editor in chief of the McMaster Textbook of Internal Medicine South Asia Edition.

What key points should physicians practicing in nonendemic areas keep in mind when treating patients returning from a tropical country with fever?

The key points are that we should keep in mind that many tropical infections have overlapping features, so we should not miss the syndromic approach to the diagnosis of fever. We need to have a meticulous examination for the associated symptomatology and see whether the fever is associated with either a renal syndrome, or a hepatic syndrome, or an encephalitic syndrome.

We can accordingly think of various differential diagnoses. It is mandatory that we should exclude malaria and dengue very early. We have the rapid diagnostic test for malaria, which has to be done immediately on getting the patient and also sent for thick and thin smears for diagnosis. Also, we should do the enzyme-linked immunosorbent assay (ELISA) for the dengue nonstructural protein-1 (NS-1) antigen that becomes positive within the first 1 to 2 days of the disease. Once we have excluded dengue and malaria, we need to look for other options like the scrub typhus, leptospirosis, and chikungunya.

See also
  • Mechanisms of long COVID Following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, many people develop long COVID with various clinical manifestations. What is known about the etiology and pathogenesis of long COVID? Is the mechanism similar, to, for example, chronic fatigue syndrome after other infections? Is it possible to shorten the duration of long COVID symptoms?
  • Climate change and the emergence of new infectious diseases. Case in point: Candida auris Dr Sarah Khan from McMaster University reviews the local and global impact of climate change on infectious diseases.
  • Aspergillosis screening and treatment in patients with neutropenia Should patients with neutropenia be screened for aspergillosis, eg, with periodic galactomannan testing? Is a positive galactomannan test result without abnormal radiologic findings an indication to initiate treatment in a patient with neutropenia?
  • Epidemiologic changes in the post-COVID-19 era During the COVID-19 pandemic, many countries experienced difficulties in implementing vaccination programs and other infectious disease control measures. This affected the epidemiology of some diseases, with increase in the global number of malaria cases being an example. How significant are these epidemiologic changes for clinical practice?
  • Management in patients with dengue What management strategy is currently recommended for patients with dengue fever?

We would love to hear from you

Comments, mistakes, suggestions?

We use cookies to ensure you get the best browsing experience on our website. Refer to our Cookies Information and Privacy Policy for more details.